Aristides Capital LLC Increases Stock Position in Genpact Limited (NYSE:G)

Aristides Capital LLC grew its stake in shares of Genpact Limited (NYSE:G - Free Report) by 21.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 82,133 shares of the business services provider's stock after purchasing an additional 14,641 shares during the period. Genpact makes up 0.7% of Aristides Capital LLC's investment portfolio, making the stock its 18th largest holding. Aristides Capital LLC's holdings in Genpact were worth $3,528,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. SRH Advisors LLC bought a new stake in shares of Genpact during the 4th quarter valued at $26,000. Atlas Capital Advisors Inc. boosted its stake in Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after acquiring an additional 216 shares in the last quarter. Manchester Capital Management LLC purchased a new stake in Genpact in the fourth quarter worth about $38,000. Smartleaf Asset Management LLC increased its stake in shares of Genpact by 416.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after purchasing an additional 783 shares in the last quarter. Finally, UMB Bank n.a. lifted its holdings in shares of Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after purchasing an additional 433 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.

Genpact Stock Performance

G stock traded up $0.29 on Friday, hitting $47.00. The company had a trading volume of 414,231 shares, compared to its average volume of 1,348,622. The stock has a market cap of $8.26 billion, a price-to-earnings ratio of 16.52, a P/E/G ratio of 1.84 and a beta of 1.06. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The stock's 50-day simple moving average is $51.04 and its 200 day simple moving average is $45.72. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, equities research analysts expect that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.45%. This is a positive change from Genpact's previous quarterly dividend of $0.15. The ex-dividend date was Tuesday, March 11th. Genpact's payout ratio is 23.94%.

Wall Street Analysts Forecast Growth

G has been the topic of several recent research reports. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and upped their price target for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and raised their price objective for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Needham & Company LLC upped their target price on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Finally, Mizuho raised their price target on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Six equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $48.44.

Insider Buying and Selling at Genpact

In other news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.80% of the stock is owned by corporate insiders.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.